Mary Crowley Cancer Center

Dallas, Texas 75251

1 studies enrolling now · 10 studies all time

What they study most

Adenocarcinoma of the Gastroesophageal Junction, Advanced Solid Tumor, Advanced Solid Tumors, Advanced or Metastatic Solid Tumors, Breast Cancer, Colorectal Cancer, Esophageal Neoplasms, FGFR Mutations, FGFR Translocations, Gastric Adenocarcinoma, Gastroesophageal Cancer, Gynecologic Cancer

Studies at this site

• A Study of TAK-505 in Adults With Solid Tumors — Recruiting now
• Study of TTX-MC138 in Subjects With Advanced Solid Tumors — Running, not enrolling
• A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab — Completed
• A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors — Stopped early
• MGD009/MGA012 Combination in Relapsed/Refractory Cancer — Completed
• Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208) — Stopped early
• A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer — Stopped early
• Phase 1 and 2 Study of PX-866 and Cetuximab — Completed
• Study of PX-866 and Docetaxel in Solid Tumors — Completed
• A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma — Stopped early